{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-224037","form_type":"8-K","ticker":"SRZN","cik":"0001824893","company_name":"Surrozen, Inc./DE","filed_at":"2026-05-14T20:13:22+00:00","discovered_at":"2026-05-14T20:14:00.286110+00:00","generated_at":"2026-05-14T20:14:07.741533+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Surrozen stockholders elect two Class II directors, ratify EY auditor, approve say-on-pay on annual basis","bullets":["Elected Mace Rothenberg, M.D. (5,982,651 for, 1,107,751 withheld) and David J. Woodhouse (7,087,293 for, 3,109 withheld) as Class II directors.","Ratified Ernst & Young LLP as independent auditor for 2026: 7,744,358 for, 284 against, 27 abstain.","Advisory vote on executive compensation approved: 6,312,815 for, 776,738 against, 849 abstain, 654,267 broker non-votes.","Stockholders preferred annual say-on-pay frequency (7,068,763 votes for 1 year); board adopted annual advisory vote going forward.","Total shares represented at meeting: 7,744,669 of 11,486,707 entitled; no proposals opposed by management."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-224037","json":"https://secwatch.observer/filing/0001193125-26-224037.json","markdown":"https://secwatch.observer/filing/0001193125-26-224037.md","text":"https://secwatch.observer/filing/0001193125-26-224037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526224037/0001193125-26-224037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526224037/srzn-20260513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T20:14:07.741533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"501fb755f7d1d02c161e9e7b3ba1c9680d40c603","claim":"Surrozen, Inc./DE shareholders approved Advisory vote on executive compensation at the 2026-05-13 meeting.","evidence_excerpt":"The Company’s stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K compensation tables and narrative discussions, by the following votes: For Against Abstain Broker Non-Votes 6,312,815 776,738 849 654,267","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526224037/0001193125-26-224037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"},{"claim_id":"869e8b1e6e3024662ebd4eefbc427ddaefbe05ac","claim":"Surrozen, Inc./DE shareholders approved Election of two Class II directors to serve until 2029 Annual Meeting at the 2026-05-13 meeting.","evidence_excerpt":"The votes cast for or withheld for each director nominee, and the number of broker non-votes, were as follows: Director Nominee For Withheld Broker Non-Votes Mace Rothenberg, M.D. 5,982,651 1,107,751 654,267 David J. Woodhouse, Ph.D. 7,087,293 3,109 654,267","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526224037/0001193125-26-224037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"},{"claim_id":"8b03622c9f56e739d2e70091ed98d9c434236932","claim":"Surrozen, Inc./DE shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 at the 2026-05-13 meeting.","evidence_excerpt":"The voting results with respect to the proposal to ratify the appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2026 were as follows: For Against Abstain 7,744,358 284 27","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526224037/0001193125-26-224037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"},{"claim_id":"a9628afe4ef2c5250309290d91a17594bb159ba4","claim":"Surrozen, Inc./DE shareholders approved Advisory vote on the preferred frequency of advisory approval of executive compensation at the 2026-05-13 meeting.","evidence_excerpt":"The Company’s stockholders approved, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company’s named executive officers, by the following votes: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 7,068,763 0 21,636 3 654,267","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526224037/0001193125-26-224037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}